日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

The effects of sodium-glucose cotransporter-2 inhibitors in chemotherapy-induced cardiotoxicity and mortality in patients with cancer: a systematic review and meta-analysis

钠-葡萄糖协同转运蛋白-2抑制剂对化疗引起的癌症患者心脏毒性和死亡率的影响：系统评价和荟萃分析

期刊:Cardiooncology
影响因子:3.2
doi:10.1186/s40959-025-00343-4
Reshadmanesh, Tara; Mohebi, Reza; Behnoush, Amir Hossein; Reshadmanesh, Azadeh; Khalaji, Amirmohammad; Norouzi, Mitra; Javanmardi, Elmira; Pishdad, Reza; Jafarzadeh, S Reza; Ghondaghsaz, Elina; Chaparro, Sandra
肿瘤
毒理研究
肿瘤免疫
发表日期：2025
文献求助 收藏

Assessment of Bendopnea and Its Association With Clinical and Para-Clinical Findings in Systolic Heart Failure: A Cross-Sectional Study

收缩性心力衰竭患者弯腰呼吸困难及其与临床和辅助检查结果相关性的评估：一项横断面研究

期刊:Health Science Reports
影响因子:2.1
doi:10.1002/hsr2.70354
Javanmardi, Elmira; Reshadmanesh, Tara; Gohari, Sepehr; Behnoush, Amir Hossein; Ahangar, Hassan
心力衰竭
心血管
发表日期：2025
文献求助 收藏

Circulatory resistin levels in inflammatory bowel disease: a systematic review and meta-analysis

炎症性肠病患者循环中抵抗素水平：系统评价和荟萃分析

期刊:BMC Gastroenterology
影响因子:2.6
doi:10.1186/s12876-024-03199-7
Behnoush, Amir Hossein; Maroufi, Seyede Parmis; Reshadmanesh, Tara; Mohtasham Kia, Yasmin; Norouzi, Mitra; Mohammadi, Seyedeh Mina; Klisic, Aleksandra; Khalaji, Amirmohammad
炎症/感染
炎症
发表日期：2024
文献求助 收藏

Circulating Levels of Calprotectin as a Biomarker in Patients With Coronary Artery Disease: A Systematic Review and Meta-Analysis

循环钙卫蛋白水平作为冠状动脉疾病患者生物标志物：系统评价和荟萃分析

期刊:Clinical Cardiology
影响因子:2.3
doi:10.1002/clc.24315
Reshadmanesh, Tara; Behnoush, Amir Hossein; Farajollahi, Maedeh; Khalaji, Amirmohammad; Ghondaghsaz, Elina; Ahangar, Hassan
发表日期：2024
文献求助 收藏

Empagliflozin improves left ventricular ejection fraction and end systolic volume in patients with type 2 diabetes mellitus and coronary artery disease: a post-hoc analysis of EMPA-CARD trial

恩格列净可改善 2 型糖尿病合并冠状动脉疾病患者的左心室射血分数和收缩末期容积：EMPA-CARD 试验的事后分析

期刊:Journal of Diabetes and Metabolic Disorders
影响因子:1.6
doi:10.1007/s40200-024-01393-8
Ghanbari, Samin; Gohari, Sepehr; Reshadmanesh, Tara; Mahjani, Mahsa; Arsang-Jang, Shahram; Ismail-Beigi, Faramarz; Dadashi, Mohsen; Chiti, Hossein; Asgari, Atieh; Taheri, Homa; Zolfkhani, Ozra; Ahangar, Hassan
糖尿病
代谢
发表日期：2024
文献求助 收藏

First Case of Macrocephaly, Dysmorphic Facies, and Psychomotor Retardation Harboring Co-inherited Variants in HERC1 and PMP22 Genes from Iran: Two Novel Variants

伊朗首例携带HERC1和PMP22基因共遗传变异的巨头畸形、面部畸形和精神运动发育迟缓病例：两种新变异

期刊:Archives of Iranian Medicine
影响因子:1
doi:10.34172/aim.31593
Reshadmanesh, Azadeh; Dehdahsi, Shima; Ahangari, Fatemeh; Kahrizi, Kimia; Kariminejad, Ariana; Mahdavi, Shokouh Sadat; Talebi, Saeed; Najmabadi, Hossein
发育与干细胞
HERC1
PMP22
发表日期：2024
文献求助 收藏

Empagliflozin improves high-sensitive cardiac troponin-I and high-density lipoprotein cholesterol in patients with type 2 diabetes mellitus and coronary artery disease: a post-hoc analysis of EMPA-CARD Trial

恩格列净可改善 2 型糖尿病合并冠状动脉疾病患者的高敏心肌肌钙蛋白 I 和高密度脂蛋白胆固醇：EMPA-CARD 试验的事后分析

期刊:Journal of Diabetes and Metabolic Disorders
影响因子:1.6
doi:10.1007/s40200-023-01305-2
Taheri, Homa; Chiti, Hossein; Reshadmanesh, Tara; Gohari, Sepehr; Jalilvand, Ahmad; Arsang-Jang, Shahram; Ismail-Beigi, Faramarz; Ghanbari, Samin; Dadashi, Mohsen; Asgari, Atieh; Mahjani, Mahsa; Karbalaee-Hasani, Amir; Ahangar, Hassan
糖尿病
代谢
发表日期：2023
文献求助 收藏

The effect of EMPAgliflozin on markers of inflammation in patients with concomitant type 2 diabetes mellitus and Coronary ARtery Disease: the EMPA-CARD randomized controlled trial

EMPAgliflozin 对同时患有 2 型糖尿病和冠状动脉疾病的患者炎症标志物的影响：EMPA-CARD 随机对照试验

期刊:Diabetology & Metabolic Syndrome
影响因子:3.4
doi:10.1186/s13098-022-00951-5
Sepehr Gohari #, Tara Reshadmanesh #, Hadi Khodabandehloo, Amir Karbalaee-Hasani, Hassan Ahangar, Shahram Arsang-Jang, Faramarz Ismail-Beigi, Mohsen Dadashi, Samin Ghanbari, Homa Taheri, Mojtaba Fathi, Muhammad Javad Muhammadi, Reyhaneh Mahmoodian, Atieh Asgari, Mohammadreza Tayaranian, Mehdi Moharr
代谢
糖尿病
发表日期：2022
文献求助 收藏

Study rationale and design of a study of EMPAgliflozin's effects in patients with type 2 diabetes mellitus and Coronary ARtery disease: the EMPA-CARD randomized controlled trial

EMPAgliflozin 对 2 型糖尿病合并冠状动脉疾病患者疗效研究的理论依据和设计：EMPA-CARD 随机对照试验

期刊:BMC Cardiovascular Disorders
影响因子:2.3
doi:10.1186/s12872-021-02131-1
Gohari, Sepehr; Reshadmanesh, Tara; Khodabandehloo, Hadi; Fathi, Mojtaba; Ahangar, Hassan; Arsang-Jang, Shahram; Ismail-Beigi, Faramarz; Ghanbari, Samin; Dadashi, Mohsen; Muhammadi, Muhammad Javad; Gohari, Sheida; Ghaffari, Saeid
糖尿病
代谢
发表日期：2021
文献求助 收藏

The Evaluation and Comparison of Transcriptionally Targeted Noxa and Puma Killer Genes to Initiate Apoptosis Under Cancer-Specific Promoter CXCR1 in Hepatocarcinoma Gene Therapy

在肝癌基因治疗中，通过转录靶向Noxa和Puma Killer基因启动癌细胞特异性启动子CXCR1诱导细胞凋亡的评估与比较

期刊:Hepatitis Monthly
影响因子:0.6
doi:10.5812/hepatmon.38828
Khoshtinat Nikkhoi, Shahryar; Heydarzadeh, Hedieh; Ranjbar, Saeed; Salimi, Fatemeh; Aghaeifard, Masoud; Alavian, Seyed Moayed; Reshadmanesh, Azadeh
CR1
肿瘤
凋亡
表观遗传
肿瘤免疫
Apoptosis
基因治疗
肝癌
细胞生物学
发表日期：2016
文献求助 收藏